IRadimed Corporation (IRMD)
IRadimed Statistics
Share Statistics
IRadimed has 12.72M shares outstanding. The number of shares has increased by 0.4% in one year.
| Shares Outstanding | 12.72M |
| Shares Change (YoY) | 0.4% |
| Shares Change (QoQ) | 0.33% |
| Owned by Institutions (%) | 54.75% |
| Shares Floating | 8.02M |
| Failed to Deliver (FTD) Shares | 25 |
| FTD / Avg. Volume | 0.06% |
Short Selling Information
The latest short interest is 148.74K, so 1.17% of the outstanding shares have been sold short.
| Short Interest | 148.74K |
| Short % of Shares Out | 1.17% |
| Short % of Float | 1.86% |
| Short Ratio (days to cover) | 3.51 |
Valuation Ratios
The PE ratio is 36.23 and the forward PE ratio is 34.69. IRadimed's PEG ratio is 3.08.
| PE Ratio | 36.23 |
| Forward PE | 34.69 |
| PS Ratio | 9.51 |
| Forward PS | 6.9 |
| PB Ratio | 8.03 |
| P/FCF Ratio | 39.55 |
| PEG Ratio | 3.08 |
Enterprise Valuation
IRadimed has an Enterprise Value (EV) of 644.78M.
| EV / Sales | 8.8 |
| EV / EBITDA | 29.36 |
| EV / EBIT | 25.16 |
| EV / FCF | 36.59 |
Financial Position
The company has a current ratio of 8.84, with a Debt / Equity ratio of 0.
| Current Ratio | 8.84 |
| Quick Ratio | 7.62 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 22.15% and Return on Invested Capital is 19.34%.
| Return on Equity | 22.15% |
| Return on Assets | 19.56% |
| Return on Invested Capital | 19.34% |
| Revenue Per Employee | $457.76K |
| Profits Per Employee | $120.21K |
| Employee Count | 160 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.62 |
Taxes
| Income Tax | 5.04M |
| Effective Tax Rate | 20.77% |
Stock Price Statistics
The stock price has increased by 20.2% in the last 52 weeks. The beta is 0.83, so IRadimed's price volatility has been higher than the market average.
| Beta | 0.83 |
| 52-Week Price Change | 20.2% |
| 50-Day Moving Average | 54.59 |
| 200-Day Moving Average | 51.37 |
| Relative Strength Index (RSI) | 40.85 |
| Average Volume (20 Days) | 39.9K |
Income Statement
In the last 12 months, IRadimed had revenue of 73.24M and earned 19.23M in profits. Earnings per share was 1.52.
| Revenue | 73.24M |
| Gross Profit | 56.35M |
| Operating Income | 21.96M |
| Net Income | 19.23M |
| EBITDA | 21.96M |
| EBIT | 21.96M |
| Earnings Per Share (EPS) | 1.52 |
Balance Sheet
The company has 52.23M in cash and 154.69K in debt, giving a net cash position of 52.08M.
| Cash & Cash Equivalents | 52.23M |
| Total Debt | 154.69K |
| Net Cash | 52.08M |
| Retained Earnings | 56.79M |
| Total Assets | 98.33M |
| Working Capital | 66.73M |
Cash Flow
In the last 12 months, operating cash flow was 25.62M and capital expenditures -8.01M, giving a free cash flow of 17.62M.
| Operating Cash Flow | 25.62M |
| Capital Expenditures | -8.01M |
| Free Cash Flow | 17.62M |
| FCF Per Share | 1.39 |
Margins
Gross margin is 76.94%, with operating and profit margins of 29.99% and 26.26%.
| Gross Margin | 76.94% |
| Operating Margin | 29.99% |
| Pretax Margin | 33.14% |
| Profit Margin | 26.26% |
| EBITDA Margin | 29.99% |
| EBIT Margin | 29.99% |
| FCF Margin | 24.06% |
Dividends & Yields
IRMD pays an annual dividend of $0.62, which amounts to a dividend yield of 0.85%.
| Dividend Per Share | $0.62 |
| Dividend Yield | 0.85% |
| Dividend Growth (YoY) | 13.33% |
| Payout Ratio | 41.33% |
| Earnings Yield | 2.76% |
| FCF Yield | 2.53% |
Analyst Forecast
The average price target for IRMD is $72, which is 42.7% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $72 |
| Price Target Difference | 42.7% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 36.34 |
| Piotroski F-Score | 7 |